Article
Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Thoracic cancer - 1 Apr 2024
Akita Takahiro, Ariyasu Ryo, Kakuto Sho, Miyadera Keiki, Kiritani Ayu, Tsugitomi Ryosuke, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Tasaka Sadatomo, Nishio Makoto
Abstract excerpt
BACKGROUND: It is difficult to predict gene mutations individually based on clinical background alone. Tumor markers may help to predict each gene mutation. Identifying tumor markers that can predict gene mutation will facilitate timely genetic testing and intervention. METHODS: We selected 134 cases of advanced or recurrent ALK-positive and 172 cases of advanced or recurrent EGFR-positive lung cancer from our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.